Sartorius Stedim Biotech 配当と自社株買い
配当金 基準チェック /06
Sartorius Stedim Biotech配当を支払う会社であり、現在の利回りは0.41%です。
主要情報
0.4%
配当利回り
-7.3%
バイバック利回り
| 総株主利回り | -6.9% |
| 将来の配当利回り | 0.5% |
| 配当成長 | -5.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | €0.690 |
| 配当性向 | 38% |
最近の配当と自社株買いの更新
Recent updates
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 25
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up
Oct 15Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 11Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 21Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Jul 12Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24決済の安定と成長
配当データの取得
安定した配当: DIMはFrench市場で注目すべき配当金を支払っていないため、支払いが安定しているかどうかを確認する必要はありません。
増加する配当: DIMはFrench市場で注目すべき配当金を支払っていないため、支払額が増加しているかどうかを確認する必要はありません。
配当利回り対市場
| Sartorius Stedim Biotech 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (DIM) | 0.4% |
| 市場下位25% (FR) | 2.0% |
| 市場トップ25% (FR) | 5.5% |
| 業界平均 (Life Sciences) | 0.7% |
| アナリスト予想 (DIM) (最長3年) | 0.5% |
注目すべき配当: DIMの配当金 ( 0.41% ) はFrench市場の配当金支払者の下位 25% ( 2.04% ) と比べると目立ったものではありません。
高配当: DIMの配当金 ( 0.41% ) はFrench市場の配当金支払者の上位 25% ( 5.52% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: DIM French市場において目立った配当金を支払っていません。
株主配当金
キャッシュフローカバレッジ: DIM French市場において目立った配当金を支払っていません。